SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kevin Podsiadlik who wrote (3859)6/3/2001 2:31:46 PM
From: Mike M  Read Replies (1) of 5582
 
Could be....But the two concepts aren't mutually exclusive. No doubt that there is little reason to be short a stock that is trading at $7.44 when Wrigley is about to pay them $3 a share for their money losing operation.

I am less concerned with the retail short interest than with the hedge fund short interest. Yes, the shorts might be back depending, of course, on what might cause the rise in price. The promises from both shorts and longs on this company have failed to come to fruition.

I always thought the line was that an INCREASE in short position was supposed to be encouraging as it provided more potential upside via the short squeeze.

Don't kid yourself Kevin. If the short interest loses their ability to contain the rallies then a short squeeze is entirely possible.

There are a lot of things left for management to solve. Not the least of which, are:

1) The resolution of the QGLY lawsuit,
2) Complete the sale of the gum manufacturing business,
3) Resolve JV issues w/ SWMAY or get on with a new partner,
4) Partner up to get Zicam overseas...
etc.

All are on management's plate and should take center stage this year. The proof will be in the pudding. No predictions from me...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext